This news alert comes from Debbie Nicholson at allvoices.com…
“Generic medications seem to be having their share of problems today. Generics are developed to provide low-cost medications to patients and to provide the same qualities as the name brand medication would not to increase the problems of the disease/illness.
The drug Keppra which is a brand-name seizure medication was approved in 2009 and was then sold. Patients who were then switched to Levetiracetam are now experiencing on-going seizures that did not occur while they were on the drug Keppra.
Generic medications being changed from one another is not uncommon in this day and age. Someone always think they can make one which is equivalent to the brand drug or prior generic and it can be developed in such a way it will be more cost-effective for patients needing the medications.
The University Hospital in Newark, New Jersey specifically states their opinion about AED’s (anti-epileptic drug) medications that basically substitutions of generics may be alright in certain conditions, but epileptics need to check with primary care physician before taking or receiving any generic substitutions. They also clearly state in no uncertain terms that the difference between brand medication in epilepsy and generic has a major difference. That these drugs could inhibit control of seizures in persons.
Now it is being stated that persons taking this new generic could lose driving privileges due to the fact it can onset more seizures, it will also impair them from employment or school with time lost. There have been cases indicated of injuries from the drug. It was noted that at least 59% of patients on this medication had more recurring seizures. Forty nine percent note was more severe side effects such as vomiting and weakness. On top of the usual side effects more intense ones have been documented such as psychotic episodes.
Past Studies Should Have Been An Indicator
In June 2010, the journal Epilepsia had published a study on patients and having their anti seizure medication changed over. It validating the medical groups at large of their apprehensions of generic brand medications not being able to perform as equally as to the brand name medications. Due to the recent events of this latest generic brand drug the Epilepsy Foundation is now making it one of its top priorities of exchanging brand name medications for generics due to the recent rash of side effects and developments on the latest switch.”
P.S. Here are some places where you can get name-brand Keppra at a low price:
Keppra Patient Assistance Program http://www.patientassistance.com/profile/ucbpharma-196/
Deeply Discounted Drugs without Insurance http://epilepsytalk.com/2010/03/18/deeply-discounted-drugs-without-insurance/
Find out what others think and have to say about Keppra, go to: Keppra — What People Are Saying http://epilepsytalk.com/2010/10/15/keppra-%E2%80%93-what-people-are-saying%E2%80%A6-2/
To subscribe to Epilepsytalk.com and get the latest articles by email, simply go to the bottom box of the right column and click on “Sign me up!”